PT-141, also known as Bremelanotide, is a synthetic peptide derived from melanocortin receptor agonists. Research literature describes it as interacting primarily with melanocortin receptors in the central nervous system. Experimental studies examine its receptor binding properties and neuroendocrine signaling pathways related to melanocortin receptor activation. See More
